SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables of $953K in Q1 FY2026

Q1 FY2026 accounts payables was $953K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$953K-6.6% QoQ
Last fiscal yearDec 2025
$549K— YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
549K USD
Year-over-year change
—

Accounts Payables vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Accounts Payables for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BLCOBausch + Lomb CorporationLTM Jun 2026$33.86M USD-44.5%-17.0%0.6%
GKOSGlaukos CorporationLTM Jun 2026$21.13M USD+4575.2%+37.7%3.4%
ALCAlcon Inc.LTM Sep 2026$18.49M USD-52.0%—0.2%
OCULOcular Therapeutix, Inc.LTM Mar 2026$2.83M USD+241.0%+12.6%5.4%
STAASTAAR Surgical CompanyLTM Apr 2026$2.5M USD-66.2%—0.9%
OCSOculis Holding AGLTM Mar 2026CHF 1.63M CHF-62.8%—323.1%
SGHTSight Sciences, Inc.LTM Mar 2026$1.28M USD-223.1%-20.6%1.6%
SGPSpyGlass Pharma, Inc. Common StockFY2025$549K USD———
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$274K USD-97.7%+57.5%3.6%
RXSTRxSight, Inc.LTM Mar 2026$22K USD-101.1%-0.4%0.0%
Peer median (excluding SGP) —-62.8%+6.1%1.6%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.